International Journal of Molecular Sciences, Volume 23, Issue 7
2022 April-1 - 656 articles
Cover Story: Calcific aortic valve disease (CAVD) is a progressive inflammatory disorder characterized by valvular interstitial cell (VIC) osteodifferentiation, leading to valve leaflet calcification and impairment movement. Runt-related transcription factor 2 (Runx2), the master transcription factor involved in VIC osteodifferentiation, modulates the expression of other osteogenic molecules. We designed and obtained vascular cell adhesion molecule (VCAM)-1 targeted lipopolyplexes suitable for systemic administration and targeted delivery of shRNA-Runx2 to osteoblast-differentiated VIC. Our results identify these nanocarriers as a new directed vehicle that could be instrumental in developing novel strategies for blocking the progression of CAVD using a targeted nanomedicine approach. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.